XSpray Pharma AB (publ)

ISIN SE0020353555Filings at the FI

At a glance

Most recent filing on May 9, 2024 — an option exercise by Per Andersson on May 2, 2024.

We hold 6 visible filings, going back to May 2, 2024.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 6 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 6. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Per Andersson Chief executive officer
75,000 SEKOption exercise
TradedMay 2, 2024FiledMay 9, 2024
Per Andersson Chief executive officer
75,000 SEKOption exercise
TradedMay 2, 2024FiledMay 9, 2024
Anders Ekblom Chair of the board
500 sharesOption exercise
TradedMay 2, 2024FiledMay 5, 2024
Christine Lind Board member
666 sharesOption exercise
TradedMay 2, 2024FiledMay 5, 2024
Maris Hartmanis Board member
2,385 sharesOption exercise
TradedMay 2, 2024FiledMay 2, 2024